- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02086383
Physical Activity and Self-Efficacy After Pulmonary Rehabilitation
Short Term Effects of Pulmonary Rehabilitation on Level of Physical Activity and Self-Efficacy in Patients With Chronic Obstructive Pulmonary Disease.
The purpose of this study is to investigate whether pulmonary rehabilitation (PR) is effective in increasing level of (a) physical activity (PA) and (b) self-efficacy in patients with chronic obstructive pulmonary disease (COPD).
PR is an evidence-based multidisciplinary approach consisting primarily of a supervised exercise program with educational components. It has demonstrated high efficacy in improving dyspnoea, health-related quality of life (HRQoL) and functional exercise capacity in patients with COPD. Despite these improvements, there is no conclusive evidence that these benefits translate to an increase in PA in patient's day-to-day life. This is of concern as low PA is a predictor of all cause mortality, correlated with lower HRQoL, increased level of dyspnoea and higher number of hospital admissions in this group of patients.
Self-efficacy is found to be an instigating force in forming intention to exercise and in maintaining practice for an extended time. Self-efficacy may be the key in determining whether a patient translates the improvement in exercise tolerance to actually being more physically active. Based on current knowledge, there is insufficient evidence that self-efficacy increases after pulmonary rehabilitation and no correlation has been made between level of self-efficacy and level of PA in these group of patients.
Hence this study aims to find out whether the existing PR program increases level of PA and self-efficacy. Correlation between level of PA and self-efficacy will be made.
Study Overview
Status
Conditions
Detailed Description
The intervention group will consist of all patients with chronic obstructive pulmonary disease (COPD) referred to Guy's and St Thomas' Hospital (GSTT) pulmonary rehabilitation. A sample of 30 is anticipated as this is the maximum number of patients who could be enrolled in the 3 month recruitment period in Guy's and St. Thomas' Hospital.
- The patient information sheet, together with the referral for PR, will be posted to the patients. Patients will be informed about the study details in the patient information sheet. This will include the fact that they have to wear an accelerometer for 5 to 7 days prior to starting the program. These accelerometers will be collected thereafter. Instructions on the use of the accelerometers will be given. They will also be informed that any personal information will strictly be kept confidential and that the results will be used for analysis in the study.
- Written consent will be taken on initial assessment if patient agrees to participate in the study.
- The Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) questionnaire will be administered. It consists of 15 questions and will take less than 10 minutes to complete.
- The patient will undertake 14 sessions of PR under supervision to successfully complete the program. The program is held at Guy's and St Thomas' Hospital.
- The PRAISE questionnaire will be administered again after completion of the program. Patients will be asked to wear the accelerometers again to track their physical activity. After 5 to 7 days of use, the accelerometers will be collected either from their address or via stamped postage.
No changes will be made to the current pulmonary rehabilitation program.
No control group is present in the study as pulmonary rehabilitation is the standard of care and it is not ethical to withhold pulmonary rehabilitation from patients with COPD.
The null hypothesis would be that there is no difference in physical activity and self-efficacy before and after pulmonary rehabilitation. The statistical test used will be a paired sample t-test to determine the change in a) physical activity and b)self-efficacy after pulmonary rehabilitation.
Correlation analysis will be made between self-efficacy and physical activity with a) Anxiety and depression (Hospital anxiety and depression scale), b)Functional exercise capacity (6 minute walk test) and c) COPD Assessment test.
A Pearson or Spearman correlations will be done depending on whether or not the data is normally distributed.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
London
-
City of Westminster, London, United Kingdom, SE1 7EH
- Recruiting
- St. Thomas' Hospital
-
Contact:
- Noor Diana Mohamed Sani
- Phone Number: 4407852599168
- Email: noor.sani.13@ucl.ac.uk
-
Principal Investigator:
- Noor Diana Mohamed Sani
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients who fulfill the current inclusion criteria for referral to pulmonary rehabilitation in Guy's and St Thomas' Hospital.
- Have chronic obstructive pulmonary disease or other respiratory conditions.
- Are aware of the about the referral and details of the program.
- Have consented and are able to attend the program.
- A diagnosis of COPD confirmed by spirometry (Forced Expiratory Volume in 1 second/Forced Vital Capacity < 0.70 after bronchodilator) (GOLD, 2014)
Exclusion Criteria:
- No evidence of COPD on spirometry
- Acute exacerbations within last 4-6 weeks requiring hospital admission
- Evidence of ischemic heart disease/ acute changes on ECG
- Uncontrolled hypertension
- Inability to exercise independently or musculoskeletal/neurological conditions which would prevent completion of the course or limit participation in the course
- Lung cancer
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients with COPD
This is an observational study of patients with chronic obstructive pulmonary disease (COPD) who attend pulmonary rehabilitation, which is the routine standard of care in Guy's and St. Thomas' Hospital, London.
It lasts for 14 sessions, twice a week and primarily consists of a supervised exercise program and educational sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in physical activity level after pulmonary rehabilitation
Time Frame: Baseline measurement and after the program (approx Week 10)
|
Physical activity is measured using the Actigraph accelerometer, which is a small light weight device clipped onto a waist belt.
Its output is vector magnitude units, steps, energy expenditure and activity intensity level.
Patients will wearing the device for 5 to 7 days, before and after the program.
The pulmonary rehabilitation program consists of 14 sessions, twice a week.
|
Baseline measurement and after the program (approx Week 10)
|
|
Change in level of Self-Efficacy using the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) questionnaire scores
Time Frame: Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) questionnaire is a questionnaire measuring the level of self-efficacy.
It consists of 15 questions on a 4-point scale.
It takes less than 10 minutes to complete.
|
Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 6-Minute Walk Test distance after pulmonary rehabilitation
Time Frame: Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
The 6-Minute Walk Test is a test of functional exercise capacity which is routinely used in pulmonary rehabilitation programs.
|
Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
|
Change in Hospital Anxiety and Depression Scale (HADS) questionnaire score
Time Frame: Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
HADS consists of 14 questions and takes less than 10 minutes to complete.
It measures the level of anxiety and depression.
|
Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
|
Change in COPD Assessment Test score
Time Frame: Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
The COPD Assessment Test is an 8-item questionnaire which determines the impact of chronic obstructive pulmonary disease on the patient's wellbeing and daily life.
It takes less than 5 minutes to complete.
|
Baseline, and after pulmonary rehabilitation program (approx Week 10)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Noor Diana Mohamed Sani, University College, London
- Study Chair: Leyla Osman, Dr, University College London, Guy's and St. Thomas' Hospital
- Study Director: Lynn McDonnell, MSc, Guy's and St Thomas' NHS Foundation Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5380/001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Strados Labs, Inc.WithdrawnChronic Obstructive Pulmonary Disease (COPD)United States
-
Pulmatrix Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States